title: [Results of an open study for evaluating the effectiveness and tolerance of adjuvant administration of the ISF nutrient program in HIV positive patients].
abstract: HIV positive patients usually show a gradual deterioration of their general condition and the laboratory key values which are accompanied by the resulting negative effects on their subjective condition. This study showed a very good stabilization of HIV positive patients by using the complex ISF nutrient program over a period of ten or 15 months. Only a very low proportion of antiviral and antibiotic supply had been given. The ratio did not change over the entire testing period of 15 months. The mortality rates observed here were a fraction of the AIDS mortality rates that are otherwise published. The data of this study also show a very good benefit/risk relationship for the patients, which can be derived from the overall favorable statements on the tolerance.
authors.affiliation: BioPan Zeitgemässe Ernährung GmbH & Co KG, Mariapfarr, Osterreich.
authors.forename: N
authors.initials: N
authors.lastname: Fuchs
authors.forename: G
authors.initials: G
authors.lastname: Markolin
authors.forename: B
authors.initials: B
authors.lastname: Kuklinski
authors.forename: R
authors.initials: R
authors.lastname: Jäger
authors.forename: N
authors.initials: N
authors.lastname: Zelch
authors.forename: I
authors.initials: I
authors.lastname: Gurh
authors.forename: G
authors.initials: G
authors.lastname: Schicka
authors.forename: K
authors.initials: K
authors.lastname: Neumann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D017252:CD3 Complex / Q000032:analysis; D016516:CD4-CD8 Ratio; D005260:Female; D005527:Food, Fortified; D006679:HIV Seropositivity / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D019247:HIV Wasting Syndrome / Q000276:immunology / Q000401:mortality / Q000628:therapy; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D016176:T-Lymphocyte Subsets / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D017252:CD3 Complex